241 related articles for article (PubMed ID: 36073735)
1. PAR2: The Cornerstone of Pancreatic Diseases.
Suhaj P; Olejar T; Matej R
Physiol Res; 2022 Nov; 71(5):583-596. PubMed ID: 36073735
[TBL] [Abstract][Full Text] [Related]
2. Mapping transmembrane residues of proteinase activated receptor 2 (PAR
Suen JY; Adams MN; Lim J; Madala PK; Xu W; Cotterell AJ; He Y; Yau MK; Hooper JD; Fairlie DP
Pharmacol Res; 2017 Mar; 117():328-342. PubMed ID: 27993717
[TBL] [Abstract][Full Text] [Related]
3. Protease-activated receptor-2 exerts contrasting model-specific effects on acute experimental pancreatitis.
Laukkarinen JM; Weiss ER; van Acker GJ; Steer ML; Perides G
J Biol Chem; 2008 Jul; 283(30):20703-12. PubMed ID: 18511423
[TBL] [Abstract][Full Text] [Related]
4. Proteinase-activated receptor-2: key role of amino-terminal dipeptide residues of the tethered ligand for receptor activation.
Al-Ani B; Hansen KK; Hollenberg MD
Mol Pharmacol; 2004 Jan; 65(1):149-56. PubMed ID: 14722246
[TBL] [Abstract][Full Text] [Related]
5. Protease-activated receptor 2 in colon cancer: trypsin-induced MAPK phosphorylation and cell proliferation are mediated by epidermal growth factor receptor transactivation.
Darmoul D; Gratio V; Devaud H; Laburthe M
J Biol Chem; 2004 May; 279(20):20927-34. PubMed ID: 15010475
[TBL] [Abstract][Full Text] [Related]
6. Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2.
Miike S; McWilliam AS; Kita H
J Immunol; 2001 Dec; 167(11):6615-22. PubMed ID: 11714832
[TBL] [Abstract][Full Text] [Related]
7. Serine proteases and protease-activated receptor 2 mediate the proinflammatory and algesic actions of diverse stimulants.
Cattaruzza F; Amadesi S; Carlsson JF; Murphy JE; Lyo V; Kirkwood K; Cottrell GS; Bogyo M; Knecht W; Bunnett NW
Br J Pharmacol; 2014 Aug; 171(16):3814-26. PubMed ID: 24749982
[TBL] [Abstract][Full Text] [Related]
8. Proteinase-activated receptor-2: physiological and pathophysiological roles.
Coelho AM; Ossovskaya V; Bunnett NW
Curr Med Chem Cardiovasc Hematol Agents; 2003 Mar; 1(1):61-72. PubMed ID: 15317291
[TBL] [Abstract][Full Text] [Related]
9. The PAR2 signal peptide prevents premature receptor cleavage and activation.
Liu B; Lee G; Wu J; Deming J; Kuei C; Harrington A; Wang L; Towne J; Lovenberg T; Liu C; Sun S
PLoS One; 2020; 15(2):e0222685. PubMed ID: 32078628
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase D and Gβγ mediate sustained nociceptive signaling by biased agonists of protease-activated receptor-2.
Zhao P; Pattison LA; Jensen DD; Jimenez-Vargas NN; Latorre R; Lieu T; Jaramillo JO; Lopez-Lopez C; Poole DP; Vanner SJ; Schmidt BL; Bunnett NW
J Biol Chem; 2019 Jul; 294(27):10649-10662. PubMed ID: 31142616
[TBL] [Abstract][Full Text] [Related]
11. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.
Loew D; Perrault C; Morales M; Moog S; Ravanat C; Schuhler S; Arcone R; Pietropaolo C; Cazenave JP; van Dorsselaer A; Lanza F
Biochemistry; 2000 Sep; 39(35):10812-22. PubMed ID: 10978167
[TBL] [Abstract][Full Text] [Related]
12. A polymorphic protease-activated receptor 2 (PAR2) displaying reduced sensitivity to trypsin and differential responses to PAR agonists.
Compton SJ; Cairns JA; Palmer KJ; Al-Ani B; Hollenberg MD; Walls AF
J Biol Chem; 2000 Dec; 275(50):39207-12. PubMed ID: 10995771
[TBL] [Abstract][Full Text] [Related]
13. Binding of a highly potent protease-activated receptor-2 (PAR2) activating peptide, [3H]2-furoyl-LIGRL-NH2, to human PAR2.
Kanke T; Ishiwata H; Kabeya M; Saka M; Doi T; Hattori Y; Kawabata A; Plevin R
Br J Pharmacol; 2005 May; 145(2):255-63. PubMed ID: 15765104
[TBL] [Abstract][Full Text] [Related]
14. Interdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducins.
Sevigny LM; Zhang P; Bohm A; Lazarides K; Perides G; Covic L; Kuliopulos A
Proc Natl Acad Sci U S A; 2011 May; 108(20):8491-6. PubMed ID: 21536878
[TBL] [Abstract][Full Text] [Related]
15. Collagenolytic matrix metalloproteinases antagonize proteinase-activated receptor-2 activation, providing insights into extracellular matrix turnover.
Falconer AMD; Chan CM; Gray J; Nagashima I; Holland RA; Shimizu H; Pickford AR; Rowan AD; Wilkinson DJ
J Biol Chem; 2019 Jun; 294(26):10266-10277. PubMed ID: 31110047
[TBL] [Abstract][Full Text] [Related]
16. Proteolytic activation of the protease-activated receptor (PAR)-2 by the glycosylphosphatidylinositol-anchored serine protease testisin.
Driesbaugh KH; Buzza MS; Martin EW; Conway GD; Kao JP; Antalis TM
J Biol Chem; 2015 Feb; 290(6):3529-41. PubMed ID: 25519908
[TBL] [Abstract][Full Text] [Related]
17. The role of trypsin, trypsin inhibitor, and trypsin receptor in the onset and aggravation of pancreatitis.
Hirota M; Ohmuraya M; Baba H
J Gastroenterol; 2006 Sep; 41(9):832-6. PubMed ID: 17048046
[TBL] [Abstract][Full Text] [Related]
18. Thrombin cleaves and activates the protease-activated receptor 2 dependent on thrombomodulin co-receptor availability.
Heuberger DM; Franchini AG; Madon J; Schuepbach RA
Thromb Res; 2019 May; 177():91-101. PubMed ID: 30861432
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin S causes inflammatory pain via biased agonism of PAR2 and TRPV4.
Zhao P; Lieu T; Barlow N; Metcalf M; Veldhuis NA; Jensen DD; Kocan M; Sostegni S; Haerteis S; Baraznenok V; Henderson I; Lindström E; Guerrero-Alba R; Valdez-Morales EE; Liedtke W; McIntyre P; Vanner SJ; Korbmacher C; Bunnett NW
J Biol Chem; 2014 Sep; 289(39):27215-27234. PubMed ID: 25118282
[TBL] [Abstract][Full Text] [Related]
20. Proteinase-activated receptor 2: differential activation of the receptor by tethered ligand and soluble peptide analogs.
Al-Ani B; Wijesuriya SJ; Hollenberg MD
J Pharmacol Exp Ther; 2002 Sep; 302(3):1046-54. PubMed ID: 12183662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
